Haoxiangni Health Food Co.Ltd(002582) 4 issued the annual report on April 28. In 2021, the company achieved an operating revenue of 1.281 billion yuan, a year-on-year decrease of 57.32%; The net profit attributable to the parent company was 616341 million yuan, a year-on-year decrease of 97.14%; The basic earnings per share is 0.13 yuan.
Meanwhile, Haoxiangni Health Food Co.Ltd(002582) released the performance report for the first quarter of 2022. In the first quarter, the company's operating revenue was 372 million yuan, a year-on-year increase of 14.29%; The net profit attributable to the parent company was 8.5676 million yuan, a year-on-year decrease of 76.21%.
Haoxiangni Health Food Co.Ltd(002582) said that in 2021, the enterprise was adversely affected by various complex factors, making it more difficult to operate. Under the leadership of the board of directors, the management of the company, focusing on the established business plan, increased product research and development, optimized channel construction, strengthened brand publicity, and exceeded the business objectives set at the beginning of the year.
The annual report shows that the company's retail business is mainly an omni-channel sales network such as e-commerce, monopoly and supermarket. E-commerce and monopoly sales are an important part of the company's sales. During the reporting period, e-commerce revenue accounted for 32.67% of operating revenue and monopoly revenue accounted for 27.21%. Offline franchised stores are distributed in some areas inside and outside Henan Province. The business model is supplemented by direct sales and dominated by franchise.
The annual report shows that in 2021, the company focused on "jujube + food and medicine homology", continued to accelerate the speed of scientific and technological progress and achievement transformation, and continuously developed and innovated healthy food. In 2021, the company's R & D expenses were 341876 million yuan, accounting for 2.67% of the operating revenue, and the R & D expenses increased by 1.54% compared with 2020
The company has made a number of breakthroughs in technology and innovation. Low GI and clear food to meet the consumption demand of people who are afraid of sugar for more than one meal a day; "Crispy" oil meets the "crispy" demand of consumers. The listing of new products firmly grasped the new trend of market trend, improved the performance growth of the company, and the listing of new products created a sales performance of 50 million yuan.
The annual report shows that in 2021, the missyou project incubated by the company achieved an operating revenue of 134854 million yuan from November to December; The jujube coffee project achieved an operating revenue of 160992 million yuan in the second half of the year, and some other new projects achieved results, thus realizing the growth of the company's performance. One enterprise invested by the company through the fund cooperated with the head venture capital institution has been listed, and several others are currently in the process of listing, and the invested assets have increased significantly.
"2022 is the 30th anniversary of the company." Haoxiangni Health Food Co.Ltd(002582) said in the annual report that in 2022, the company will focus on the strategic goal of "10 billion market value, 10 billion revenue and 100 year brand" and the brand positioning of "high-end red jujube Haoxiangni Health Food Co.Ltd(002582) ", and continuously improve the brand strength by strengthening brand building, brand management and brand publicity. It is planned to develop 3-5 kinds of jujube functional products in 2022. The R & D cost budget in 2022 is 35.22 million yuan, with a year-on-year increase of 3.02%.
